After more than a decade of global consultation, polycystic ovary syndrome (PCOS) – a condition that affects one in eight women – has been renamed. The hormonal disorder, estimated to impact 170 million women worldwide, will now be known as polyendocrine metabolic ovarian syndrome (PMOS). The name change was published in the Lancet and announced at the European Congress of Endocrinology in Prague on Tuesday…The renaming was spearheaded by the endocrinologist Prof Helena Teede, the director of Melbourne’s Monash Centre for Health Research and Implementation… The first thing Maddy Mavrikis was told by her GP when she was diagnosed with...